Results of a first-in-human phase 1 trial of anchored IL-12 drug conjugate (ANK-101)

tolododekin alfa (ANK-101) - Ankyra Therap

https://www.abstractsonline.com/pp8/#!/20273/presentation/10496

Jong Chul Park1; Brendan Curti2; Marcus O. Butler3; Gail Iodice4; Sailaja Battula4; Joseph Elassal4; James L. Gulley5; Jeffery Schlom5; Howard L. Kaufman4; John M. Kirkwood6

Mar 26, 2025